Literature DB >> 26687593

Venetoclax targets BCL2 in chronic lymphocytic leukaemia.

Vicki Brower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26687593     DOI： 10.1016/S1470-2045(15)00576-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloid leukemia: a case report.

Authors:  Bingshan Liu; Roshni Narurkar; Madhura Hanmantgad; Wahib Zafar; Yongping Song; Delong Liu
Journal:  Front Med       Date:  2018-05-21       Impact factor: 4.592

2.  Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport.

Authors:  Juliana Velez; Rongqing Pan; Jason T C Lee; Leonardo Enciso; Marta Suarez; Jorge Eduardo Duque; Daniel Jaramillo; Catalina Lopez; Ludis Morales; William Bornmann; Marina Konopleva; Gerald Krystal; Michael Andreeff; Ismael Samudio
Journal:  Oncotarget       Date:  2016-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.